• Martin Teicher

    Director of Research; Professor

    Martin Teicher, MD, PhD

    McLean Hospital Title: Director, Developmental Biopsychiatry Research Program Harvard Medical School Title: Associate Professor of Psychiatry Martin Teicher, MD, PhD, has been director of the Developmental Biopsychiatry Research Program at McLean Hospital since 1988. He was director of the former Developmental Psychopharmacology Laboratory (now the Laboratory of Developmental Neuropharmacology), and is currently an associate professor of psychiatry at Harvard Medical School. Dr. Teicher is a member of the editorial board of the Journal of Child and AdolescentPsychopharmacologyCurrent Pediatric Reviews, and Current Psychosomatic Medicine. He is a member of the Scientific Advisory Council of the Juvenile Bipolar Research Foundation, and has been part of Harvard University's Brain Development Working Group. He has served on or chaired numerous review committees for the National Institutes of Health, published more than 150 articles, and has received numerous honors.
    Research Focus:
    Dr. Teicher’s Developmental Biopsychiatry Research Program was founded in 1988 with the aim of improving the lives of children, adolescents, and adults by exploring the cause of psychiatric disorders that arise during development, and by creating medical devices for their assessment. Dr. Teicher is particularly focused on the enduring effects of childhood maltreatment. Research reveals a strong link between physical, sexual, and emotional maltreatment and bullying, and depression, anxiety, post-traumatic stress, and substance abuse. Research pioneered by Dr. Teicher’s lab shows that childhood maltreatment alters brain structure and function, depending on the type of abuse and the stage of development. The lab’s research goals include identifying sensitive periods when brain regions are maximally vulnerable to early life stress and associated with greatest risk for mental illness, assessing whether alterations in brain structure can predict future risk for substance abuse, and evaluating novel treatments—including sensory enrichment, brain exercises, acupressure, and mindfulness—for ADHD, depression, and learning disorders,.

    • SPESIALSEMINAR 1: Professor Martin Teicher
      9:00 - 15:00
    • Exploring the difference between maltreated and non-maltreated patients with the same disorder
      11:45 - 12:30
      C: Developmental trajectories from maltreatment to substance abuse
      14:00 - 15:15